Skip to main content
NCBI home page
eLife logoLink to eLife
. 2017 May 11;6:e24214. doi: 10.7554/eLife.24214

Digitizing mass spectrometry data to explore the chemical diversity and distribution of marine cyanobacteria and algae

Tal Luzzatto-Knaan 1,*,†, Neha Garg 1,†, Mingxun Wang 2, Evgenia Glukhov 3, Yao Peng 4, Gail Ackermann 5, Amnon Amir 5, Brendan M Duggan 1, Sergey Ryazanov 6, Lena Gerwick 3, Rob Knight 5, Theodore Alexandrov 1,6, Nuno Bandeira 1,2, William H Gerwick 1,3,*, Pieter C Dorrestein 1,2,3,*
Editor: Emmanuel Gaquerel7
PMCID: PMC5441867  PMID: 28492366

Abstract

Natural product screening programs have uncovered molecules from diverse natural sources with various biological activities and unique structures. However, much is yet underexplored and additional information is hidden in these exceptional collections. We applied untargeted mass spectrometry approaches to capture the chemical space and dispersal patterns of metabolites from an in-house library of marine cyanobacterial and algal collections. Remarkably, 86% of the metabolomics signals detected were not found in other available datasets of similar nature, supporting the hypothesis that marine cyanobacteria and algae possess distinctive metabolomes. The data were plotted onto a world map representing eight major sampling sites, and revealed potential geographic locations with high chemical diversity. We demonstrate the use of these inventories as a tool to explore the diversity and distribution of natural products. Finally, we utilized this tool to guide the isolation of a new cyclic lipopeptide, yuvalamide A, from a marine cyanobacterium.

DOI: http://dx.doi.org/10.7554/eLife.24214.001

Research Organism: Other

eLife digest

Cyanobacteria and algae are found in all oceans around the globe. Like plants, they can use sunlight as a source of energy in a process called photosynthesis. As a result, these organisms are important sources of oxygen and another vital nutrient called nitrogen for other marine organisms. Many of these organisms also produce a variety of other chemicals known as “natural products” to help them to survive in their environments. Some of these natural products have shown potential as medicinal drugs. The search for new chemicals with useful medicinal properties has led researchers to collect samples of algae and cyanobacteria from various locations around the world.

An approach called mass spectrometry is often used to identify new chemicals because it can provide information about the structure of a molecule based on how much its fragments weigh. Luzzatto-Knaan et al. used mass spectrometry to search for new chemicals in samples of algae and cyanobacteria that had been collected by diving and snorkeling in a wide variety of tropical marine environments over several decades.

The experiments reveal that the organisms in these samples produce a diverse range of chemicals, most of which were previously unknown and have not been found in other similar environmental collections. The data were grouped together into eight major collection areas covering different parts of the tropics. The samples from some areas contained a wider variety of chemicals than others. Within each collection area, some molecules were found to be very common whereas others were only present at specific locations. To highlight the distribution of these natural products, Luzzatto-Knaan et al. display the data on a world map.

Further experiments used this approach as a guide to extract a previously unknown chemical called yuvalamide A from a marine cyanobacterium. The next challenge would be to associate the geographical patterns of chemicals to their potential ecological roles. This approach offers a new way to explore large-scale collections of environmental samples to discover and study new natural products.

DOI: http://dx.doi.org/10.7554/eLife.24214.002

Introduction

The marine environment is extraordinarily rich in both biological and chemical diversity. It is estimated that nearly 90% of all organisms living on earth inhabit marine and coastal environments (Blunt et al., 2012; Kiuru et al., 2014). Moreover, marine organisms are recognized as an extremely rich source of novel chemical entities that have potential utility in medicine, personal health care, cosmetics, biotechnology and agriculture (Gerwick and Moore, 2012; Kiuru et al., 2014; La Barre, 2014; Rastogi and Sinha, 2009). Marine cyanobacteria (‘blue-green algae’) are considered the most ancient group of oxygenic photosynthetic organisms, having appeared on earth some three billion years ago. It is thought that their extensive evolutionary history explains, at least in part, the extensive nature of their structurally-unique and biologically-active natural products (Burja et al., 2001; Chlipala et al., 2011; Schopf, 2012; Whitton and Potts, 2012). Indeed, since the 1970s, several hundred unique chemical entities have been discovered from marine cyanobacteria, and these have been found to possess a remarkable spectrum of biological activities including anticancer, anti-inflammatory, antibacterial, anti-parasitic, neuromodulatory, and antiviral, among others (Blunt et al., 2015; Nunnery et al., 2010; Tan, 2007; Villa and Gerwick, 2010). Examples of marine cyanobacterial natural products that are under investigation for anticancer applications include the cyclodepsipeptides apratoxin A and F, the nitrogen-containing lipid curacin A and the lipopeptides dolastatin 10 and carmaphycin B (Bai et al., 1990; Blokhin et al., 1995; Luesch et al., 2001a, 2001b; Pereira et al., 2012; Tidgewell et al., 2010). These natural product templates have inspired the synthesis of lead compounds using medicinal chemistry approaches, and have resulted in one clinically approved drug (Brentuximab vedotin) for the treatment of cancer; several others are in various stages of clinical and preclinical evaluation (Gerwick and Moore, 2012; Luesch et al., 2001a; 2001b; Tan et al., 2010; Tidgewell et al., 2010; Uzair et al., 2012). Unfortunately, such fruitful natural product materials, rich with so much unexplored potential, oftentimes disappear upon completion of academic careers and closing of laboratories.

In this study, we used a mass spectrometry based approach to digitize (convert to data format that can be stored, shared and analyzed by computational tools) the chemical inventory of an established marine cyanobacteria and algae collection in order to better evaluate its diversity and probe for novel natural products. Additionally, while a number of biologically potent natural products have been isolated from marine cyanobacteria and algae, the overall molecular profile of these organisms has not been compared to other classes of bacteria or terrestrial/freshwater cyanobacteria (Chlipala et al., 2011). To address this, we analyzed the crude extracts of a relatively large number of algae and cyanobacteria, as well as their derived chromatographic fractions, by high resolution liquid chromatography tandem mass spectrometry (HR-LC-MS/MS). We then compared this metabolomics dataset to four existing public datasets [Mass spectrometry Interactive Virtual Environment (MassIVE) repository] within the Global Natural Product Social (GNPS) platform (Wang et al., 2016).

The marine samples used in this study were derived from over 300 field collections from locations in the Indian, Indo-Pacific, Central and South Pacific, and Western Atlantic (Caribbean) oceans with initial field taxonomic identifications as predominantly cyanobacteria and macro-algae. It should be noted that these are environmental samples, and therefore are inherently communities of organisms and are not single axenic cultures. Additionally, three samples were from non-axenic laboratory cultures of the cyanobacteria Phormidium (No.1646) and Lyngbya (No. 1933, 1963); the latter two were recently classified as Moorea (Supplementary file 1) (Engene et al., 2012). From both a chemical and biosynthetic perspective, these three cultures represent the most intensively studied organisms in this dataset (Engene et al., 2012; Kleigrewe et al., 2015; Mevers et al., 2014; Pereira et al., 2010; Williamson et al., 2002). While these and other of our cultured filamentous cyanobacteria cannot yet be grown axenically, their MS-derived molecular data represent marine cyanobacterial metabolomics markers that aid in data analysis. Furthermore, in exploring the chemical diversity of marine cyanobacterial and algal assemblages, we established a cartographic platform that combines LC-MS data and geographic locations that facilitates the discovery of new chemical scaffolds as well as identifies geographical areas of high chemical diversity (Boeuf and Kornprobst, 2009). The discovery of such ‘hotspots’ may reveal new patterns of phylogenetic diversity as well as identify geographical areas with enhanced bioprospecting opportunities.

Assessment of the chemical diversity of these marine cyanobacterial and algal collections involved four major steps: (1) Collection - including permits, field collection, transport, extraction, fractionation and metadata recording; (2) Data acquisition and digitization in public repository - by LC-HRMS/MS to generate molecular fingerprints; (3) Data analysis and visualization - clustering similarly structured compounds as molecular families within the GNPS platform, identification of known molecules and assessing the richness and diversity between as well as within samples; (4) Discovery - identification of geographical patterns of distribution, differentiating common from regiospecific natural products, dereplication of new derivatives and the discovery of previously uncharacterized natural products.

Results

Over the past 30 years, a significant number of cyanobacterial and algal collections were obtained under the appropriate governmental permits using scuba diving and snorkeling in the Caribbean (Puerto Rico, Grenada, Panama), Central and South Pacific (Hawaii, Palmyra Atoll, French Polynesia, Fiji), Indo-Pacific (Indonesia, Papua New Guinea), and Indian Oceans (Madagascar, South Africa). These collections represent natural assemblages of benthic filamentous marine cyanobacteria and various classes of macro-algae (Rhodophyta, Chlorophyta and Phaeophyceae). Each collection was extracted (CH2Cl2/MeOH, 2:1) and fractionated using a standardized vacuum liquid chromatography protocol (Supplementary file 1). Approximately 2600 fractions originating from 317 marine collections, including the unfractionated crude samples, were analyzed by reversed phase ultra-performance liquid chromatography (RP-UPLC) coupled with high resolution quadrupole time-of-flight mass spectrometry (HR-qTOF-MS) to obtain retention times and MS and tandem MS/MS fragmentation spectra (LC-MS/MS). Nearly 6000 spectra were collected for each LC-MS/MS run, generating in excess of 15.6 million spectra for the samples in this study.

These data were analyzed using the GNPS platform enabling the extensive organization of the LC-MS/MS data (Wang et al., 2016). GNPS detected features (i.e. molecules) based on MS/MS spectra and MS intensities. Further, some of these MS/MS spectra were identified by matching to spectral libraries available on GNPS. Even in the absence of MS/MS spectral matching to known reference MS/MS spectra, GNPS molecular networking can associate structurally related molecules that exhibit similar MS/MS fragmentation patterns into molecular families (Watrous et al., 2012; Yang et al., 2013).

Comparative metabolomics and chemical diversity of large scale datasets

Few tools allow assessment of the chemical diversity within large and diverse MS datasets such as those in the current study (Bouslimani et al., 2014; Charlop-Powers et al., 2015; Luzzatto-Knaan et al., 2015; Purves et al., 2016). To determine whether this collection of marine cyanobacterial and algal communities possessed unique chemical diversity, the LC-MS/MS data were analyzed with publicly available data sets accessed via the GNPS-MassIVE database (For datasets see methods) (Wang et al., 2016). These datasets include LC-MS/MS data from terrestrial and marine actinobacteria (1000 samples), lichens (132 samples), marine sponges and corals (260 samples) and freshwater cyanobacteria (535 samples). Collection of all datasets was acquired using tandem mass spectrometry to obtain unique fragmentation fingerprints for each detected molecule.

To evaluate the chemical diversity of these source materials, we employed diverse MS-based informatic approaches, including multivariate analyses and molecular networking. Multivariate approaches, such as principal component analysis (PCA) and partial least squares-discriminant analysis, (PLS-DA), have been widely employed to assess the chemical diversity of metabolomics data (Worley and Powers, 2013). Here, for comprehensive metabolomics analysis, we applied principal coordinate analysis (PCoA), a statistical method that provides an overview of the dissimilarities between samples based on the metabolome of an individual sample relative to all other samples in the analysis (He et al., 2015) The relatedness between samples is calculated by the dissimilarity distance matrix and displayed in a three-dimensional plot where each sphere represents a sample with specific MS/MS features. We utilized the Bray-Curtis distance matrix applied to all MS/MS features, as exported from GNPS, using the QIIME platform (Caporaso et al., 2010). The separation of the samples in PCoA space highlights the differences between the various origins of the samples (Figure 1A). The lichen samples separate from the marine associated samples, although they overlap the spatial distributions of some cyanobacteria populations, perhaps because most lichens contain cyanobacteria, bacteria and fungi (Mushegian et al., 2011). Interestingly, among the five environmental samples, the marine cyanobacteria/algae and freshwater cyanobacteria are more similar in their metabolomics profiles than any other of the source materials, even though the two aquatic environments are quite distinct (Figure 1A). Nevertheless, while presenting the highest similarity compared to the other datasets, the marine cyanobacteria/algae and freshwater cyanobacteria samples show a clear differentiation in their chemical inventories (Figure 1B). To quantify the common and differential chemical features driving these distances, we generated a Venn diagram using the MS/MS features. (Figure 1C,). This analysis revealed that only 13.7% of the marine cyanobacteria/algae molecular features overlapped with other datasets, highlighting that 86.3% were features unique to these collections. Among the molecular commonalities, a number of the mass spectrometry signals were identified as matches to reference spectra in GNPS. These included a mixture of primary metabolites such as amino acids, fatty acids, structural lipids, pheophytin and pheophorbide A (chlorophyll derived products), as well as common mass spectrometry background signals such as formate clusters, plasticizers and polymers. Remarkably, despite being most similar by PCoA analysis, no reference MS/MS spectra of the known freshwater cyanobacterial natural products matched with our marine cyanobacteria and algal collection dataset.

Figure 1. MS/MS features as generated in GNPS are shown for marine cyanobacteria and algae (green), marine and terrestrial actinobacteria (blue), lichens (red), freshwater cyanobacteria (yellow) and corals (pink).

Figure 1.

Open in a new tab

(A) PCoA plots of 300 samples randomly selected from each dataset display the distance between samples based on molecular features using Bray-Curtis dissimilarity matrix. (B) Marine cyanobacteria and algae and freshwater cyanobacteria. Laboratory cultures of Phormidium 1646, Lyngbya 1933 are highlighted in red circles. Each sphere represents the full sample metabolome (C) Venn diagram display of overlapping MS/MS features. Percentage of overlapping features with the marine cyanobacteria and algae dataset are given in parenthesis in their respective colors (Supplementary file 1).

DOI: http://dx.doi.org/10.7554/eLife.24214.003

In exploring the chemical diversity of the marine cyanobacteria and algae communities, we hypothesized that either the organism collected (cyanobacterial or algal) or the geographical location was responsible for sample-to-sample metabolomics differences (Figure 2). Our PCoA analysis did not indicate differentiation based on field annotations as algal versus cyanobacterial (Figure 2A), and the non-significant clustering based on geographical origin, highlights the vast chemical diversity of samples within the same region (Figure 2B). PCA, the most common dimensionality reduction and visualization method used for metabolomics analysis, displayed a parallel outcome with minor trends being observed (Supplementary file 1, Figure 2—figure supplement 1).

Figure 2. MS/MS feature diversity between and within sampling sites.

PCoA plots of crude extract molecular features using Bray-Curtis, dissimilarity matrix. Each point represents a single sample and points are colored by metadata. (A) PCoA plot shows the distance between samples based on field identified classification. (B) PCoAs color coded by geographical origin shows the distance of all locations together (B: upper panel) and the individual PCoA plots of the four collection sites with most samples (B: lower panel). Laboratory cultures of Phormidium 1646, Lyngbya 1933 and Lyngbya 1963 are highlighted in orange circles.

DOI: http://dx.doi.org/10.7554/eLife.24214.004

Figure 2.

Figure 2—figure supplement 1. PCA plot of crude extracts of cyanobacteria and algae collections.

Figure 2—figure supplement 1.

PCA was performed using Bruker Profile Analysis software version 2.1. Samples are displayed by collection location as described in the legend. NAC-Curacao, PAB-Panama Bocas del Toro, PAC-Panama Coiba, PAG-Panama Gulf of Chiriqui, PAP-Panama Portobelo, PAL-Palmyra Atoll, PNG-Papua New Guinea.
DOI: http://dx.doi.org/10.7554/eLife.24214.005
Open in a new tab

Construction of fraction libraries has become a common strategy to make more efficient the discovery of bioactive molecules in natural products studies so as to reduce sample complexity for biological screening as well as increase the titer of minor constituents (Bugni et al., 2008; Harvey et al., 2015). In the current analysis, the fraction library yielded over five times the number of molecular features compared to the crude extracts, thereby enabling a more thorough assessment of chemical richness and diversity (Figure 3A). The fraction library resulted in 1094 molecular families compared to 132 in the crude extract analysis. This tenfold difference highlights the advantage of using fraction libraries for chemical and biological assay screens. By comparing the number of features as well as the number of underlying spectra for a given molecular family (Nguyen et al., 2013), we could identify particular chemical scaffolds that are more diverse in their structural variations and are more abundant in our collections. For example, the barbamide molecular family (Figure 3B) is comprised of 40 molecular features represented in 985 individual spectra and found in 75 collections. By contrast, the palmyrolide A molecular family has only two associated features and consists of 32 spectra that are found in five collections (Figure 3B). Using a rarefaction analysis, both the crude extracts and the fraction library were found to level off under the current experimental conditions of analysis, indicating that the sample collections are saturating the chemical diversity of these materials (Figure 3A).

Figure 3. Chemodiversity and richness of molecular features based on MS/MS data.

(A) Rarefaction curve of cyanobacteria collection library showing the chemical richness of crude extracts vs. the fraction library. (B) Abundance of molecular families: Bars represent the number of features and spectra comprising each molecular family clustered by GNPS molecular networking. (C) Bar chart depicting both the total number of extracts from a given location and the percent contribution of unique features to the entire dataset. (D) Pie chart representing the percentage of unique molecular features attributed to origin of the sample. HI-Hawaii, NAC-Curacao, PAB-Panama Bocas del Toro, PAC-Panama Coiba, PAG-Panama Gulf of Chiriqui, PAP-Panama Portobelo, PAL-Palmyra Atoll, PNG-Papua New Guinea.

DOI: http://dx.doi.org/10.7554/eLife.24214.006

Figure 3.

Figure 3—figure supplement 1. Molecular network of marine cyanobacterial natural products with annotated molecular families.

Figure 3—figure supplement 1.

(A) Molecular networking generated using MSV000078568/MSV000078892 datasets by http://gnps.ucsd.edu and visualized in Cytoscape. A-malyngamides [M+H]+, B-barbamides [M+H]+, C-curacins [M+H]+, D-hectochlorins [M+H]+, E-viequeamides [M+Na]+, F-carmabins [M+H]+, G-palmyramides [M+Na]+, H-palmyramides [M+H]+, I-dolastatins [M + 2 hr]+, J- cyanolides [M+H]+, K-apratoxins [M+H]+, L-hoiamides [M+H]+, M-hoiamides [M+Na]+, N-majusculamides [M+Na]+, O-hectochlorins [M+Na]+, P-palmyrolides [M+H]+. Spectral data dereplicated by fragmentation patterns present in spectral libraries available on GNPS. Nodes are color-coded by the geographical origin of the sample and labeled with parent mass (m/z). Edge thickness represents the cosine similarity score. Insets on right hand side depict the (B) barbamide and (C) cyanolide molecular families. Shown for each are the standard library spectrum (upper panel) and the matching sample spectrum from within the same node (lower panel).
DOI: http://dx.doi.org/10.7554/eLife.24214.007
Figure 3—figure supplement 2. Dereplication of the apratoxin molecular family.

Figure 3—figure supplement 2.

Identification of apratoxin B based on library standards enabled dereplication of 5 known apratoxins (A, D, F, G, and H). Additional apratoxin derivatives were characterized based on mass differences of functional groups.
DOI: http://dx.doi.org/10.7554/eLife.24214.008
Figure 3—figure supplement 3. Dereplication and spatial distribution for new derivatives of the barbamide molecular family.

Figure 3—figure supplement 3.

Based on barbamide (1) dereplication, peaks assigned to fragments enable the characterization of N-demethylbarbamide (2) and a substitution of the Phe and Leu groups as a new barbamide derivative (3).
DOI: http://dx.doi.org/10.7554/eLife.24214.009
Open in a new tab

Mapping the distribution of marine natural products

To identify locations of high chemical diversity among sampling sites represented in this study (locations with more unique natural products compared to other regions), we compared the MS/MS features found only in a single location to the overall diversity of the entire dataset (Figure 3C and D). To do this, we normalized the contribution of features from a single location to a percentage contribution as some locations were sampled more frequently than others based on metadata information collected across three decades (Figure 3C). For example, approximately 4% of all MS/MS features contributing to the overall diversity are from Panama-Bocas del Toro (PAB) whereas about 7–8% are each contributed from Panama-Portobelo (PAP) and Palmyra Atoll (PAL), and 20% are from Papua New Guinea (PNG) (Figure 3D).

To explore the chemical nature of differentially produced metabolites in the marine cyanobacterial and algal sample collections, GNPS based molecular networking was used and the network was visualized in Cytoscape (For molecular network and Cytoscape file see Materials and methods, Figure 3—figure supplement 1) (Purves et al., 2016; Shannon et al., 2003; Watrous et al., 2012). As MS/MS spectral alignment detects molecular features, a set of structurally related features connected by edges is termed a ‘molecular family’. Experimental MS/MS spectra were dereplicated (also described as ‘finding known unknowns’ by the metabolomics community) against the community contributed mass spectral ‘GNPS library’ and third party spectral libraries including MassBank, HMDB, ReSpect and NIST 2014 housed within GNPS analysis infrastructure (Horai et al., 2010; Johnson and Lange, 2015; Sawada et al., 2012; Wang et al., 2016; Wishart et al., 2013). This is currently the largest molecular network generated and only possible through the GNPS interface (Wang et al., 2016). From the more than 15.6 million spectra collected, 6249 MS/MS spectra were dereplicated to existing publicly accessible reference data, with 91 of the matches to previously characterized cyanobacterial and algal derived natural products from 30 molecular families (Nguyen et al., 2013). The spectral library matches from the marine cyanobacteria/algae collection included: 74 matches to the GNPS library, 7 matches to the NIH pharmacologically active compounds library, 3 matches to the NIH natural product library, 1 match to the NIH clinical collection, 1 match to the FDA natural products library and 5 matches to the Faulkner legacy library. This is a match rate of about 0.04% which is much lower than database matches of the average untargeted metabolomics experiments (1.8%, [Wang et al., 2016]) and metabolomics analyses of model samples such as E. coli, human cell lines, mice or humans (da Silva et al., 2015). The low match rate to existing natural product libraries within GNPS highlights that these marine cyanobacterial/algal communities are significantly underexplored from a chemical perspective.

The hundreds of unannotated molecular families from these samples suggest that they contain a significant number of natural products that remain uncharacterized. Molecular networking allows putative structural propagation through a molecular family because most molecules of similar structure fragment similarly. By investigating selected molecular families, we identified previously characterized metabolites and previously undescribed derivatives (Supplementary file 2 and Figure 3—figure supplements 2 and 3). For example, we identified the spectral cluster representing the apratoxin molecular family by a spectral match to the apratoxin B library standard. Further dereplication of this molecular family using literature information and manual analysis of MS/MS spectra revealed several known apratoxin derivatives (A, D, F, G, H) (Figure 3—figure supplement 2) (Luesch et al., 2002; Tidgewell et al., 2010; Watrous et al., 2012; Yang et al., 2013). Additional apratoxin derivatives are suggested on the basis of mass differences of common functional groups (Figure 3—figure supplement 2). Further, GNPS identified a molecular family comprised of the barbamides (Orjala and Gerwick, 1996). Within this molecular family, we were able to deduce several candidate derivatives based on fragmentation patterns and presence of chlorine isotopes (Figure 3—figure supplement 1 and Figure 3—figure supplement 3 [1]) (Orjala and Gerwick, 1996; Yang et al., 2013). For example, a 14 Da decrease from the y ion of barbamide most likely results from loss of the amide methyl group, leading to N-desmethyl barbamide (Figure 3—figure supplement 3 [2]). O-desmethyl barbamide was previously published and is identifiable by the loss of 14 Da from the characteristic MS/MS fragment containing the three chlorine atoms (m/z 242.98) (Kim et al., 2012). The 34 Da reduction from the y ion appears to be associated with the substitution of the Phe group by Leu, a conservative hydrophobic replacement for A-domains that accept Phe in the NRPS-based biosynthesis of barbamide. Such a conservative substitution has previously been observed in other NRPS biosynthetic systems (Figure 3—figure supplement 3 [3]) (Flatt et al., 2006). This exchange of amino acids gives rise to a new molecular entity; however, it is reminiscent of related compounds, such as dysidin, which was isolated from the cyanobacteria-harboring sponge Dysidea herbacea (Ilardi and Zakarian, 2011).

Because a majority (55%, Figure 3D) of molecules detected in this dataset were found in more than one sampling location, we explored the spatial distribution and abundance of specific natural products using binning networks. For this visualization, the abundance/presence of a metabolite was correlated to the eight collection sites. In the network, each node represents a distribution pattern of molecules, where the node size and color correspond to the relative number of features that share the same distribution (Figure 4). Of the 256 conceivable regiospecific patterns (based on the eight collection sites) some molecules share similar distribution patterns, while some distribution patterns are absent or very minor in their abundance (light colored nodes). To visualize the distribution of select molecules identified via molecular networking, in our eight major sampling sites, MS/MS feature intensity values were projected onto a 2D geographical map based on GPS coordinates using the open-source tool ‘ili (an open-source tool for 2D and 3D data visualization created by our laboratories, https://github.com/ili-toolbox/ili [Protsyuk et al., 2017], available as a Google Chrome app; a copy is archived at https://github.com/elifesciences-publications/ili) (see legend of Figure 4 for more information). For example, out of the 33,481 detected features, dolastatin 10 along with 72 other chemical features share the same widespread distribution pattern (Curaçao (NAC), PAB, Panama-Coiba (PAC), PAL, PAP, PNG), while palmyramide A and 3033 other chemical features are endemic to PAL, at least within the scope of this data set, and are not found in any of the other sampling locations. Additionally, while barbamide is widely distributed, putative analogs are encountered relatively infrequently (Figure 4B and Figure 3—figure supplement 3).

Figure 4. Spatial maps showing the geographic distribution of selected cyanobacterial natural products.

Figure 4.

Open in a new tab

(A) Features were binned by their distribution patterns across the eight main geographical locations, each bin represented by a node with edges linking bins differing by one location. Number of features in each bin is presented according to size and color scale from white (0) to red (10,000) as indicated by the scale bar on the top. Spatial patterns are represented for selected natural products within these bins. Inserts in each map display zoomed-in sections of Panama, Curaçao and Papua New Guinea. Each sample is designated to a specific coordinate based on GPS coordinates of the collection site (multiple samples are represented by spots placed around the collection site). See the URL provided below. (B) Spatial maps display chemogeographical distribution and abundance of barbamide (1) and two barbamide analogs (2, 3). Relative abundance is presented by Jet color scale from low (blue) to high (red). HI-Hawaii, NAC-Curaçao, PAB-Panama Bocas del Toro, PAC-Panama Coiba, PAG-Panama Gulf of Chiriqui, PAP-Panama Portobelo, PAL-Palmyra Atoll, PNG-Papua New Guinea.

(To use the open source tool ‘ili please open the following link in Google Chrome: http://ili-toolbox.github.io/?cyano/bg.png;cyano/intensities.csv. Please wait until the data is loaded and visualized, then click on the Mapping submenu, and change the scale to Logarithmic, and Color map to Jet. For flipping through maps corresponding to different molecules, please click on the name of the molecule shown above the colorbar and select another molecule either with a click or with up-down arrow keys. Alternatively, you can refer to the example tab and choose cyanobacteria natural products. If you experience any problems, please contact theodore.alexandrov@embl.de.)

DOI: http://dx.doi.org/10.7554/eLife.24214.010

Discovery of new natural products

To emphasize the application of MS-based geographic network analyses for the discovery of uncharacterized natural products, we examined several chemical features from locations of high chemical diversity, namely the PAP, PAL and PNG sites. One sample was chosen from PAP and targeted for the isolation of an m/z 536.333 molecule from a cluster with no described family members (For molecular network see Materials and methods, molecular family #483). This specific molecular feature was observed in several cyanobacterial collections of Lyngbya from PAP obtained in different years from 2007 to 2013 (collections in Dec 2007, Sept 2010 and Jan 2013). The MS/MS data indicated that this compound was peptidic and contained the amino acids glycine, valine (or N-methyl glycine), leucine or isoleucine, and 2-hydroxyvaleric acid (Hiv). The presence of this latter residue suggested it was the product of a non-ribosomal peptide synthetase (NRPS) (Kehr et al., 2011). An additional residue was observed corresponding to the fragment mass m/z 149.094, compatible with the formula C10H13O+. Further analysis of the sequential fragment losses suggested a putative structure of [Gly-Ile/Leu-Hiv-Val-C10H13O]+. A search for a putative peptide with a molecular mass m/z 536.333 in various chemical databases (Blunt et al., 2015, Blunt et al., 2012; Luzzatto-Knaan et al., 2015; http://pubs.rsc.org/marinlit/) was unsuccessful, suggesting that this natural product was uncharacterized.

In order to confirm the mass spectrometry-based partial structural assignment, we isolated and structurally characterized this natural product of mass m/z 536.333 (Figure 5, Figure 5—figure supplements 1 and 2, Supplementary file 3 [4]). Isolation of compound 4, given the common name of ‘yuvalamide A’, was guided by LC-MS analyses. NMR analysis (DMSO-d6) of the pure compound confirmed the presence of Gly, Val, Ile, and hydroxyisovaleric acid, and revealed the presence of 2,2-dimethyl-3-hydroxy-7-octynoic (Dhoya) as the C10H13O+ fragment (Figure 5, Figure 5—figure supplements 1 and 2, Supplementary file 3). These NMR-based determinations correlate well with the structural predictions obtained by mass spectrometry.

Figure 5. The molecular family and structure elucidation of a novel natural product yuvalamide A (4), isolated from a Panama-Portobelo (PAP) cyanobacterial collection.

(A) Molecular families and the spatial distribution of yuvalamide A [M+H]+ and [M+Na]+ ions are highlighted within yellow circles. MS/MS spectra display the linear structure for the non-ribosomal peptide (NRP) fragments Gly-Ile-Hiv-Val. (B) for the [M+H]+ and the (C) [M+Na]+ ions. (D) The full elucidated structure of yuvalamide A (4) as confirmed by NMR analysis (Figure 5—figure supplements 1 and 2, Supplementary file 3).

DOI: http://dx.doi.org/10.7554/eLife.24214.011

Figure 5.

Figure 5—figure supplement 1. Structure identification of yuvalamide A.

Figure 5—figure supplement 1.

(A) 1H NMR spectrum of yuvalamide A with COSY and key HMBC correlations (600 Hz, DMSO-d6). (B) HMBC correlation of Dhoya-H3 - Gly-CO. (C) HMBC correlation of Dhoya-H6 - C7 and H6-C8.
DOI: http://dx.doi.org/10.7554/eLife.24214.012
Figure 5—figure supplement 2. MS/MS fragmentation of yuvalamide A.

Figure 5—figure supplement 2.

The theoretical masses of predicted MS/MS fragments of yuvalamide A are shown in the top panel. The observed masses of these MS/MS fragments are labelled in the acquired spectrum.
DOI: http://dx.doi.org/10.7554/eLife.24214.013
Figure 5—figure supplement 3. Dereplication of yuvalamide molecular family.

Figure 5—figure supplement 3.

Additional putative yuvalamide analogs observed in the molecular family. Molecular families of [M+H]+ and [M+Na]+ ions highlighting yuvalamide A (4) (Gly-Ile-Hiv-Val-Dhoya) in yellow and the putative yuvalamide B (5) characterized as Dhoea analogue (Gly-Ile-Hiv-Val-Dhoea) in green circles. Two additional putative analogs characterized 522.3 m/z [M+H]+ (Gly-C10H17NO3-Val-Dhoya) and 572.3 m/z [M+Na]+ (Gly-Ile-MeHiv-Val-Dhoya). One analog with an [M+H]+ m/z 522.3156 (14 Da smaller than compound 4) displayed a similar, but not identical fragmentation pattern to yuvalamide A (Figure 5—figure supplement 3). The linear order we propose is Gly-[C10H17NO3]-Val-Dhoya, as the −14 Da change is located in the Ile - Hiv residue region when compared to yuvalamide A. This is likely due to the promiscuous behavior of A domains in the NRPS biosynthetic assembly. Such promiscuous behavior where one amino acid is substituted by another, is quite common in non-ribosomal peptides, and results from similar amino acids being recognized by the cognate adenylation domain (Crawford et al., 2011). Another yuvalamide analog with a 572.3303 m/z (Figure 5—figure supplement 3) that clusters with the sodiated yuvalamide molecular family possess a similar fragmentation pattern to the yuvalamide A but with an increase in 14 Da. This shift is likely due to presence of additional methyl group and the fragmentation suggests this methyl is near the Hiv residue.
DOI: http://dx.doi.org/10.7554/eLife.24214.014
Open in a new tab

The other chemical entities in the yuvalamide A molecular family were present at very low abundance, preventing their isolation and structural analysis by NMR. However, based on the structure of yuvalamide A and its fragmentation pattern by LC-ESI-MS/MS, we deduced putative structures of these co-metabolites. An analog of yuvalamide A (Figure 5—figure supplement 3 compound 5, yuvalamide B, [M+H]+ m/z 538.3487, [M+Na]+ m/z 560.3320) was detected by HRMS. Its fragmentation was nearly identical to compound 4, differing only in the fragment belonging to Dhoya, suggesting this to be the alkene analog 2,2-dimethyl-3-hydroxy-7-octenoic acid (Dhoea). Co-occurring analogs possessing the Dhoya or Dhoea unit have been observed previously in marine cyanobacterial natural extracts. The Dhoya subunit is usually the more abundant of the two, as observed in this case for yuvalamide A (Boudreau et al., 2012; Han et al., 2005, 2011; Luesch et al., 2001; Sitachitta et al., 2000; Wan and Erickson, 2001). Moreover, the geographical distribution of yuvalamide B is the same as yuvalamide A (Figure 5), supporting the proposal that these share a common biosynthetic origin. Two additional yuvalamide analogs were observed and tentative structures were assigned based on MS (Figure 5—figure supplement 3).

Discussion

Over the last 40 years, a number of academic natural product discovery programs have generated unique and significant collections from a variety of sources. However, the samples as well as the associated collection and characterization information is often buried in individual laboratory materials and documentation, and frequently this disappears with academic turnovers. To explore a new paradigm for characterizing and preserving such information over a longer time period for the community at large, we harnessed recent advances and metabolomics approaches to deeply annotate the metabolomes of these collections. We then evaluated this rich dataset along with collection information for its diversity, distribution and discovery of new natural products.

To date, biodiversity studies have mostly relied on available genomic information (Bowen et al., 2013; Passarini et al., 2015). While organisms might be phylogenetically related, their metabolomic repertoire may vary greatly. The detection of biosynthetic gene clusters indicates natural product potential, and has been successfully employed to predict new molecules, especially of the core structure (Medema and Fischbach, 2015; Medema et al., 2015; Owen et al., 2015; Walsh, 2015). However, post assembly modifications (e.g. halogenations, oxidations, methylations) are often times difficult to predict without the structures in hand, and therefore genomic analyses do not provide a complete assessment of the secondary metabolomes. Chemical diversity represents the expression of that genetic potential and offers a new strategy to explore differences and to evaluate the diversity encrypted in complex samples and various environments. Herein, we broadly inventoried the molecules that are present in a large library of field collected marine algae and cyanobacteria using LC-MS/MS. Using the mass spectrometry detectable natural products from each sample, the chemodiversity and the regional patterns of these samples were characterized.

It is reported in the literature that marine cyanobacteria are an exceptional source for diverse new natural products (Blunt et al., 2015; Burja et al., 2001; Engene et al., 2011; Kiuru et al., 2014; Tan, 2007). However, this perception is difficult to assess quantitatively in comparison to other marine or terrestrial life forms. To gain insights into how unique are the secondary metabolites of marine cyanobacteria and algae, we compared these MS data with other metabolomic data sets that are available from the public domain.

The mass spectrometry data from marine cyanobacteria/algae collections obtained over the past 30 years indicate that, at a global level, this group is rich in metabolite features that do not overlap with other available metabolomic data sets (Figure 1C). Common multivariate analyses used for metabolomics were successful in distinguishing the different datasets based on their unique metabolomic inventories.

Key to a chemical pattern analysis is the ability to organize molecules on the basis of structural features along with their associated metadata attributes. GNPS molecular networking generates molecular features that are based upon fragmentation similarity, thereby providing resolution at the individual molecular level. This approach also enables the rapid matching of spectra to known molecules by comparison with various natural product MS/MS libraries (Nguyen et al., 2016; Wang et al., 2016; Yang et al., 2013). In this regard, the MS/MS spectrum of a molecule is a unique molecular signature or barcode. When structurally similar molecules are fragmented, the resulting MS/MS spectra are very often quite similar because they contain similarly positioned labile bonds (Wang et al., 2016). Using molecular networking, a visual representation of these ‘barcodes’ is produced by grouping similar patterns. Molecular networking enables the evaluation of the MS/MS based detectable chemical space, and groups molecules that have similar biosynthetic origins and resultant structures. At the organism level (e.g. invertebrates, plants, corals), marine environments such as the Papua New Guinea archipelago (PNG) are considered to be biodiversity ‘hotspots’ (Bowen et al., 2013). However, not only is PNG a biodiversity hotspot, molecular networking quantitatively revealed that this region is rich in the presence of unique natural products compared to other sampled locations in this study (Figure 3) (Bowen et al., 2013; La Barre, 2014). Although this is demonstrated here for these marine algal and cyanobacterial collections, it would be interesting to evaluate if high biodiversity always correlates with high chemical diversity, and as a corollary, how chemical diversity changes upon a shift in biodiversity. The geographical patterns of molecule distribution could be further investigated via the tools presented here, given the appropriate sampling strategy. While molecular networking revealed the locations with lowest and highest chemical diversity, visualizing these data on a world map enabled assessment of the distribution patterns of specific molecules within the eight sampled regions. This analysis also enabled targeting samples with higher abundance of molecules of interest, and may therefore assist in characterizing exceptionally high-producers of natural products. We have demonstrated that some chemical entities were found in common to multiple locations (e.g. barbamide, dolastatin 10) whereas others appeared to be unique and endemic to specific sampling sites (e.g. hoiamide B, palmyramide) (Figure 4). This observation is supported by site resampling over several years, an insight gained as a distinctive attribute of this unique collection of marine samples.

Additional tracing of the metadata associated with a given molecular family can assist in identification of the producing organism, and facilitate future biosynthetic and ecological investigations (Coates et al., 2014; Harvey et al., 2015; Kleigrewe et al., 2015; Leal et al., 2016; Owen et al., 2013). Finally, we demonstrated the utility of this overall approach through the discovery and subsequent structural elucidation and geographical distribution of yuvalamide A (4), reported here for the first time.

Conclusion

The integration of molecular networking with geographical mapping revealed that marine algae and cyanobacteria have widely varying metabolite distributions. As we can see in this dataset most molecules are broadly distributed in disparate physical locations, whereas others are highly specific to particular locations. Whether this specificity to a given location is due to unique species with distinct metabolic capabilities, or to specific environmental factors regulating expression of these compounds, is unknown at present. Moreover, field collections are a complex mixture of microorganisms that hold a unique repertoire of natural products that may not be discoverable under laboratory conditions, even with sequenced strains. Therefore, our approach is uniquely capable of organizing the vast chemical diversity present in these complex environmental samples. Further, this approach could be used to identify locations with a higher level of chemical diversity as well as distribution patterns of natural products, potentially giving insights into their ecological roles. In turn, these perceptions may facilitate the search for novel natural products of utility to biomedicine and biotechnology.

Materials and methods

Collection and culturing

A total of 317 diverse marine cyanobacterial and benthic algae collections were hand-collected in Panama, Papua New Guinea, Hawaii, Madagascar, Palmyra Atoll, Curaçao, and a few other tropical marine sites at depths from 0.3 to 20 m with the aid of snorkel or scuba gear (Supplementary file 1). GPS location, preliminary field taxonomic identification of the specimens, and depth of collection were noted for most collections. Samples for subsequent chemical extraction were strained through a mesh bag to remove excess seawater, preserved in equal volumes of seawater and ethanol, transported to the laboratory, and stored at −4°C or −20°C until workup. Live samples of marine cyanobacteria were brought back to the laboratory in vented tissue culture flasks with 0.2 µm filtered native seawater and subsequently isolated to mono-cultures. These were cultured in SWBG-11 media with 35 g/L Instant Ocean (Aquarium Systems Inc.). Mono-cultures were grown at 28°C in a 16 hr light/8 hr dark cycle with a light intensity of ~7 µmol photon/s/m2 provided by 40 W cool white fluorescent lights. Specific collection information is described in the Supporting Information.

Extraction library

Chemistry samples were extracted repetitively with CH2Cl2:MeOH 2:1, dried in vacuo, and in most cases, fractionated into nine fractions (A-I) by silica gel vacuum liquid chromatography (VLC) using a stepwise gradient of hexanes/EtOAc and EtOAc/MeOH. Each fraction and crude extract was re-suspended at 5 mg/mL in pure DMSO and stored in 96-well plates at −20°C until analysis.

UHPLC-MS/MS analysis

The extracted metabolites were analyzed with an UltiMate 3000 UHPLC system (Thermo Scientific) using a Kinetex 1.7 µm C18 reversed phase UHPLC column (50 × 2.1 mm) and Maxis Impact Q-TOF mass spectrometer (Bruker Daltonics) equipped with an ESI source. The data were acquired in positive ionization mode for parent mass (MS1) and tandem MS for molecular fragmentation (MS2). Amount of material injected from each sample was 3.3 µg. The data were acquired in positive ionization mode for parent mass (MS1) and tandem MS for molecular fragmentation (MS2). The gradient employed for chromatographic separation was 5% solvent B (ACN/H2O/formic acid 98%/2%/0.1%) with solvent A (H2O/ACN/formic acid 98%/2%/0.1%) for 1.5 min, a step gradient of 5% to 50% B in 0.5 min, held at 50% B for 2 min, a second gradient of 50–100% B in 6 min, held at 100% B for 0.5 min, 100–5% B in 0.5 min and kept at 5% B for 0.5 min at a flow rate of 0.5 mL/min throughout the run. The MS analysis was performed on a Maxis QTOF mass spectrometer (Bruker Daltonics), controlled by the Otof Control and Hystar software packages (Bruker Daltonics), and equipped with ESI source. MS spectra were acquired as previously described (Garg et al., 2015).

Molecular networking

A molecular network was created using the online workflow at GNPS (Wang et al., 2016). To de-noise, the data was filtered by removing all MS/MS peaks within ±17 Da of the precursor m/z. MS/MS spectra were filtered by choosing only the top six peaks in the ±50 Da window throughout the spectrum. The data were clustered with MS-Cluster with a parent mass tolerance of 1.0 Da and a MS/MS fragment ion tolerance of 0.5 Da to create consensus spectra. Consensus spectra that contained less than three spectra were discarded. A network was then created where edges were filtered to have a cosine score above 0.6 and more than four matched peaks. Further edges between two nodes were kept in the network if and only if each of the nodes appeared in each other's respective top 10 most similar nodes. The spectra in the network were then searched against GNPS spectral libraries. The library spectra were filtered in the same manner as the input data. The networking output was visualized using Cytoscape 2.8.3 free software (Shannon et al., 2003) and organized using the FM3 force directed layout (Hachul and Junger, 2004). Follow the link to the GNPS molecular network of multiple datasets: http://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=e69c25e3fbcf4c09b6e0c75633565f95. Links to the cyanobacteria/algae datasets: ftp://massive.ucsd.edu/MSV000078568, ftp://massive.ucsd.edu/MSV000078892 and the corresponding network on GNPS: http://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=0837888b3dab43efa5bf9a50254c7c8f. For the Cytoscape file ftp://massive.ucsd.edu/MSV000078568/other/.

Statistics and diversity analysis

The MS/MS data tables generated by GNPS for all analyzed extracts and fractions was converted to a BIOM table (http://biom-format.org/) (McDonald et al., 2012). Each of the tables was then used for calculation the sample-sample distance metrics using binary metric (Binary-Jaccard) using QIIME (Caporaso et al., 2010) version 1.9. Principal coordinates were calculated and visualized based on various metadata categories (region, organism etc.) using EMPeror (Vázquez-Baeza et al., 2013). Rarefaction curves of 20 random iterations were generated by GNPS.

Spatial mapping of mass spectrometry data

Spatial molecular maps were created with background map from a Google Map screenshot with several regions of interest enlarged and plotted as insets to the overview map. By visual examination, we assigned to each sampling spot the (x,y) pixel coordinates on the background map based on GPS coordinates taken at the time of collection. For multiple samples from the same location, spots were placed in adjacent locations. For each node of the molecular network generated in GNPS, we considered the area under the curve of all mapped spots, scaled them from 0% to 100% and assigned colors to all intensities by using the ‘jet’ color map, color-coding low intensities with blue, high intensities red, and other intensities with a colored gradient between blue and red. The rendering of the maps was performed by the ‘ili tool for 2D and 3D spatial mapping (https://github.com/ili-toolbox/ili). The color was made gradually disappearing with highest intensity at the center of the sampling location and almost no intensity at the boundary of the spot. For this, a logarithmic combination of the default color and assigned color was used, with the coefficient exponentially depending on the distance from the sampling spot center.

Structure elucidation of yuvalamide A (4)

A preliminary structure was deduced based on a HRMS (C28H45N3O7, 8° unsaturation) and HRMS/MS (Bruker Daltonics Maxis Impact qTOF) fragment analysis. Exact masses observed were [M+H]+ m/z 536.3335 and [M+Na]+ m/z 558.3155 corresponding to a molecular formula of C28H45N3O7 (<0.9 ppm). Neutral losses of glycine, leucine/isoleucine and valine were observed. An additional loss matching the formula of 2-hydroxyisovaleric acid (Hiv) was observed suggesting yuvalamide was a non-ribosomal peptide. This MS-based fragment analysis suggested a Gly-Ile/Leu-Hiv-Val sequence with an additional C10H13O fragment. The peptide appeared to be cyclic based on degrees of unsaturation, and by database query, was a new compound.

Analysis of 2D NMR data (gCOSY, TOCSY, HSQC, HMBC) confirmed three of the five substructures (Val, Hiv, Gly) and clarified the structures of the remaining two (Figure 5—figure supplement 1, Supplementary file 3). The Ile/Leu substructure was identified as Ile from COSY correlations between the beta protons at 1.96 ppm and a methyl group at δ 0.86, the beta protons at δ 1.96 and a pair of germinal protons at δ 1.49 and 1.13, and between the geminal protons to a second methyl group at δ 0.81. Finally, a 2,2-dimethyl-3-hydroxyoctynoic acid (Dhoya) residue was similarly identified. The gem-dimethyl arrangement was revealed by key HMBC correlations from CH3-9/10Dhoya to the carbonyl carbon C-1Dhoya, quaternary carbon C-2Dhoya, and oxygenated methine CH-3Dhoya. This latter resonance was connected by COSY to a linear sequence of three methylene groups, the terminal methylene of which was long range coupled to alkynyl carbons (δC 71.7 and 84.5), one of which (δC 84.5) showed a HMBC correlation to a terminal alkynyl proton (δH 2.78). The assembly of these substructures into an overall cyclic depsipeptide structure was enabled by a key HMBC correlation between Dhoya H3 (δH 4.71) and the Gly carbonyl (δC 168.6) (Figure 5—figure supplement 1/2, Supplementary file 3). Additional HMBC correlations linking all the substructures verified the MS/MS-deduced sequence described above (Figure 5—figure supplements 1 and 2, Supplementray file 3).

Acknowledgements

The authors would like to thank Dr. Gabriel Navarro for his help with the NMR structure elucidation and Dr. Vanessa V Phelan for her valuable insights on the manuscript. TLK was supported, in part, by BARD, the United States – Israel Binational Agricultural Research and Development Fund, Vaadia-BARD Postdoctoral Fellowship Award no. FI-494–13. This work was supported by NIH grant GM107550 to PCD, LG and WHG and European Union FP7 and H2020 programmes grants No. 305259 and 634402. The authors declare no conflict of interest.

Funding Statement

The funders had no role in study design, data collection and interpretation, or the decision to submit the work for publication.

Funding Information

This paper was supported by the following grants:

  • National Institutes of Health GM107550 to William H Gerwick.

  • European Commission FP7 to Theodore Alexandrov.

  • H2020 305259 to Theodore Alexandrov.

  • Vaadia-BARD Fellowship No.FI-494-13 to Tal Luzzatto-Knaan.

  • H2020 634402 to Theodore Alexandrov.

Additional information

Competing interests

The authors declare that no competing interests exist.

Author contributions

TL-K, Conceptualization, Data curation, Formal analysis, Investigation, Methodology, Writing—original draft, Project administration, Writing—review and editing.

NG, Data curation, Formal analysis, Methodology, Writing—review and editing.

MW, Software.

EG, Methodology, Project administration.

YP, Methodology.

GA, Formal analysis, Methodology, Project administration.

AA, Formal analysis, Validation, Project administration.

BMD, Formal analysis, Validation, Methodology.

SR, Software, Visualization.

LG, Resources, Funding acquisition, Methodology.

RK, Software, Validation, Writing—review and editing.

TA, Software, Visualization, Methodology.

NB, Software, Validation, Visualization.

WHG, Conceptualization, Resources, Supervision, Funding acquisition, Methodology, Writing—review and editing.

PCD, Conceptualization, Resources, Supervision, Funding acquisition, Writing—original draft, Writing—review and editing.

Additional files

Supplementary file 1. Samples list and metadata.

Sample list and metadata are freely available upon registration at http://qiita.microbio.me Study ID:10125. Also refers to Figures 2, 3, 4 and 5.

DOI: http://dx.doi.org/10.7554/eLife.24214.015

elife-24214-supp1.xlsx (445KB, xlsx)
DOI: 10.7554/eLife.24214.015
Supplementary file 2. Supplemental table 1: GNPS molecular networking MS/MS based identification of molecules and molecular families – Refers to Figures 3 and 4.

DOI: http://dx.doi.org/10.7554/eLife.24214.016

elife-24214-supp2.docx (708.1KB, docx)
DOI: 10.7554/eLife.24214.016
Supplementary file 3. 2D NMR spectroscopic data for amino acids residues of yuvalamide A.

13C and 1H chemical shifts were determined by HSQC and HMBC spectra. Hiv = 2 hydroxyisovaleric acid (600 MHz for 1H, 125 for 13C), the solvent (DMSO-d6) and the temperature (298K).

DOI: http://dx.doi.org/10.7554/eLife.24214.017

elife-24214-supp3.docx (16.5KB, docx)
DOI: 10.7554/eLife.24214.017

Major datasets

The following datasets were generated:

Tal Luzzatto-Knaan,2015,150717_Marine_lichen_actino_freshW_coral,http://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=e69c25e3fbcf4c09b6e0c75633565f95,Publicly available at Global Natural Products Social Molecular Networking website (http://gnps.ucsd.edu/)

Tal Luzzatto-Knaan,2014,141021_BigData_06_MCS3_MMP4_p31,http://gnps.ucsd.edu/ProteoSAFe/status.jsp?task=0837888b3dab43efa5bf9a50254c7c8f,Publicly available at Global Natural Products Social Molecular Networking website (http://gnps.ucsd.edu/)

Tal Luzzatto-Knaan,Neha Garg,Mingxun Wang,Evgenia Glukhov,Yao Peng,Gail Ackermann,Amnon Amir,Brendan M Duggan,Sergey Ryazanov,Lena Gerwick,Rob Knight,Theodore Alexandrov,Nuno Bandeira,William H Gerwick,Pieter C Dorrestein,2017,GNPS_Cyanobacterial_collection_Plate31,ftp://massive.ucsd.edu/MSV000078892,Publicly available via the Mass spectrometry Interactive Virtual Environment (MassIVE) (accession no: MSV000078892)

Tal Luzzatto-Knaan,Neha Garg,Mingxun Wang,Evgenia Glukhov,Yao Peng,Gail Ackermann,Amnon Amir,Brendan M Duggan,Sergey Ryazanov,Lena Gerwick,Rob Knight,Theodore Alexandrov,Nuno Bandeira,William H Gerwick,Pieter C Dorrestein,2016,GNPS_Dorrestein_Gerwick_Cyanobacteria,ftp://massive.ucsd.edu/MSV000078568/other/,Publicly available via the Mass spectrometry Interactive Virtual Environment (MassIVE) (accession no: MSV000078568)

References

  1. Bai R, Pettit GR, Hamel E. Dolastatin 10, a powerful cytostatic peptide derived from a marine animal. inhibition of tubulin polymerization mediated through the Vinca alkaloid binding domain. Biochemical Pharmacology. 1990;39:1941–1949. doi: 10.1016/0006-2952(90)90613-P. [DOI] [PubMed] [Google Scholar]
  2. Blokhin AV, Yoo HD, Geralds RS, Nagle DG, Gerwick WH, Hamel E. Characterization of the interaction of the marine cyanobacterial natural product curacin A with the colchicine site of tubulin and initial structure-activity studies with analogues. Molecular Pharmacology. 1995;48:523–531. [PubMed] [Google Scholar]
  3. Blunt JW, Copp BR, Keyzers RA, Munro MH, Prinsep MR. Marine natural products. Natural Product Reports. 2012;29:144–222. doi: 10.1039/C2NP00090C. [DOI] [PubMed] [Google Scholar]
  4. Blunt JW, Copp BR, Keyzers RA, Munro MH, Prinsep MR. Marine natural products. Natural Product Reports. 2015;32:116–211. doi: 10.1039/C4NP00144C. [DOI] [PubMed] [Google Scholar]
  5. Boeuf G, Kornprobst JM. Biodiversity and marine chemodiversity. Biofutur. 2009:28–32. [Google Scholar]
  6. Boudreau PD, Byrum T, Liu WT, Dorrestein PC, Gerwick WH. Viequeamide A, a cytotoxic member of the kulolide superfamily of cyclic depsipeptides from a marine button Cyanobacterium. Journal of Natural Products. 2012;75:1560–1570. doi: 10.1021/np300321b. [DOI] [PMC free article] [PubMed] [Google Scholar]
  7. Bouslimani A, Sanchez LM, Garg N, Dorrestein PC. Mass spectrometry of natural products: current, emerging and future technologies. Natural Product Reports. 2014;31:718. doi: 10.1039/c4np00044g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  8. Bowen BW, Rocha LA, Toonen RJ, Karl SA, Lab T, ToBo Laboratory The origins of tropical marine biodiversity. Trends in Ecology & Evolution. 2013;28:359–366. doi: 10.1016/j.tree.2013.01.018. [DOI] [PubMed] [Google Scholar]
  9. Bugni TS, Richards B, Bhoite L, Cimbora D, Harper MK, Ireland CM. Marine natural product libraries for high-throughput screening and rapid drug discovery. Journal of Natural Products. 2008;71:1095–1098. doi: 10.1021/np800184g. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Burja AM, Banaigs B, Abou-Mansour E, Grant Burgess J, Wright PC. Marine cyanobacteria—a prolific source of natural products. Tetrahedron. 2001;57:9347–9377. doi: 10.1016/S0040-4020(01)00931-0. [DOI] [Google Scholar]
  11. Caporaso JG, Kuczynski J, Stombaugh J, Bittinger K, Bushman FD, Costello EK, Fierer N, Peña AG, Goodrich JK, Gordon JI, Huttley GA, Kelley ST, Knights D, Koenig JE, Ley RE, Lozupone CA, McDonald D, Muegge BD, Pirrung M, Reeder J, Sevinsky JR, Turnbaugh PJ, Walters WA, Widmann J, Yatsunenko T, Zaneveld J, Knight R. QIIME allows analysis of high-throughput community sequencing data. Nature Methods. 2010;7:335–336. doi: 10.1038/nmeth.f.303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Charlop-Powers Z, Owen JG, Reddy BV, Ternei MA, Guimarães DO, de Frias UA, Pupo MT, Seepe P, Feng Z, Brady SF. Global biogeographic sampling of bacterial secondary metabolism. eLife. 2015;4:e05048. doi: 10.7554/eLife.05048. [DOI] [PMC free article] [PubMed] [Google Scholar]
  13. Chlipala GE, Mo S, Orjala J. Chemodiversity in freshwater and terrestrial cyanobacteria - a source for drug discovery. Current Drug Targets. 2011;12:1654–1673. doi: 10.2174/138945011798109455. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Coates RC, Podell S, Korobeynikov A, Lapidus A, Pevzner P, Sherman DH, Allen EE, Gerwick L, Gerwick WH. Characterization of cyanobacterial hydrocarbon composition and distribution of biosynthetic pathways. PLoS One. 2014;9:e85140. doi: 10.1371/journal.pone.0085140. [DOI] [PMC free article] [PubMed] [Google Scholar]
  15. Crawford JM, Portmann C, Kontnik R, Walsh CT, Clardy J. NRPS substrate promiscuity diversifies the xenematides. Organic Letters. 2011;13:5144–5147. doi: 10.1021/ol2020237. [DOI] [PMC free article] [PubMed] [Google Scholar]
  16. da Silva RR, Dorrestein PC, Quinn RA. Illuminating the dark matter in metabolomics. PNAS. 2015;112:12549–12550. doi: 10.1073/pnas.1516878112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Engene N, Choi H, Esquenazi E, Rottacker EC, Ellisman MH, Dorrestein PC, Gerwick WH. Underestimated biodiversity as a Major explanation for the perceived rich secondary metabolite capacity of the cyanobacterial genus Lyngbya. Environmental Microbiology. 2011;13:1601–1610. doi: 10.1111/j.1462-2920.2011.02472.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Engene N, Rottacker EC, Kaštovský J, Byrum T, Choi H, Ellisman MH, Komárek J, Gerwick WH. Moorea producens gen. nov., sp. nov. and Moorea bouillonii comb. nov., tropical marine cyanobacteria rich in bioactive secondary metabolites. International Journal of Systematic and Evolutionary Microbiology. 2012;62:1171–1178. doi: 10.1099/ijs.0.033761-0. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Flatt PM, O'Connell SJ, McPhail KL, Zeller G, Willis CL, Sherman DH, Gerwick WH. Characterization of the initial enzymatic steps of barbamide biosynthesis. Journal of Natural Products. 2006;69:938–944. doi: 10.1021/np050523q. [DOI] [PubMed] [Google Scholar]
  20. Garg N, Kapono C, Lim YW, Koyama N, Vermeij MJ, Conrad D, Rohwer F, Dorrestein PC. Mass spectral similarity for untargeted metabolomics data analysis of complex mixtures. International Journal of Mass Spectrometry. 2015;377:719-717. doi: 10.1016/j.ijms.2014.06.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. Gerwick WH, Moore BS. Lessons from the past and charting the future of marine natural products drug discovery and chemical biology. Chemistry & Biology. 2012;19:85–98. doi: 10.1016/j.chembiol.2011.12.014. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Hachul S, Junger M. Drawing large graphs with a potential-field-based multilevel algorithm. Graph Drawing; Proceedings of the 12th International Conference; 2004. pp. 285–295. [DOI] [Google Scholar]
  23. Han B, Goeger D, Maier CS, Gerwick WH. The wewakpeptins, cyclic depsipeptides from a Papua New Guinea collection of the marine Cyanobacterium lyngbya semiplena. The Journal of Organic Chemistry. 2005;70:3133–3139. doi: 10.1021/jo0478858. [DOI] [PubMed] [Google Scholar]
  24. Han B, Gross H, McPhail KL, Goeger D, Maier CS, Gerwick WH. Wewakamide A and guineamide G, cyclic depsipeptides from the marine cyanobacteria Lyngbya semiplena and Lyngbya majuscula. Journal of Microbiology and Biotechnology. 2011;21:930–936. doi: 10.4014/jmb.1105.05011. [DOI] [PubMed] [Google Scholar]
  25. Harvey AL, Edrada-Ebel R, Quinn RJ. The re-emergence of natural products for drug discovery in the genomics era. Nature Reviews Drug Discovery. 2015;14:111–129. doi: 10.1038/nrd4510. [DOI] [PubMed] [Google Scholar]
  26. He Y, Caporaso JG, Jiang XT, Sheng HF, Huse SM, Rideout JR, Edgar RC, Kopylova E, Walters WA, Knight R, Zhou HW. Stability of operational taxonomic units: an important but neglected property for analyzing microbial diversity. Microbiome. 2015;3:20. doi: 10.1186/s40168-015-0081-x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  27. Horai H, Arita M, Kanaya S, Nihei Y, Ikeda T, Suwa K, Ojima Y, Tanaka K, Tanaka S, Aoshima K, Oda Y, Kakazu Y, Kusano M, Tohge T, Matsuda F, Sawada Y, Hirai MY, Nakanishi H, Ikeda K, Akimoto N, Maoka T, Takahashi H, Ara T, Sakurai N, Suzuki H, Shibata D, Neumann S, Iida T, Tanaka K, Funatsu K, Matsuura F, Soga T, Taguchi R, Saito K, Nishioka T. MassBank: a public repository for sharing mass spectral data for life sciences. Journal of Mass Spectrometry. 2010;45:703–714. doi: 10.1002/jms.1777. [DOI] [PubMed] [Google Scholar]
  28. Ilardi EA, Zakarian A. Efficient total synthesis of dysidenin, dysidin, and barbamide. Chemistry - an Asian Journal. 2011;6:2260–2263. doi: 10.1002/asia.201100338. [DOI] [PubMed] [Google Scholar]
  29. Johnson SR, Lange BM. Open-access metabolomics databases for natural product research: present capabilities and future potential. Frontiers in Bioengineering and Biotechnology. 2015;3:22. doi: 10.3389/fbioe.2015.00022. [DOI] [PMC free article] [PubMed] [Google Scholar]
  30. Kehr JC, Gatte Picchi D, Dittmann E. Natural product biosyntheses in cyanobacteria: a treasure trove of unique enzymes. Beilstein Journal of Organic Chemistry. 2011;7:1622–1635. doi: 10.3762/bjoc.7.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  31. Kim EJ, Lee JH, Choi H, Pereira AR, Ban YH, Yoo YJ, Kim E, Park JW, Sherman DH, Gerwick WH, Yoon YJ. Heterologous production of 4-O-demethylbarbamide, a marine cyanobacterial natural product. Organic Letters. 2012;14:5824–5827. doi: 10.1021/ol302575h. [DOI] [PMC free article] [PubMed] [Google Scholar]
  32. Kiuru P, D′Auria MV, Muller CD, Tammela P, Vuorela H, Yli-Kauhaluoma J. Exploring marine resources for bioactive compounds. Planta Medica. 2014;80:1234–1246. doi: 10.1055/s-0034-1383001. [DOI] [PubMed] [Google Scholar]
  33. Kleigrewe K, Almaliti J, Tian IY, Kinnel RB, Korobeynikov A, Monroe EA, Duggan BM, Di Marzo, Sherman DH, Dorrestein PC, Gerwick L, Gerwick WH. Combining mass spectrometric metabolic profiling with genomic analysis: a powerful approach for discovering natural Products from Cyanobacteria. Journal of Natural Products. 2015;78:1671–1682. doi: 10.1021/acs.jnatprod.5b00301. [DOI] [PMC free article] [PubMed] [Google Scholar]
  34. La Barre S. Marine biodiversity and chemodiversity — the treasure troves of the future. In: Grillo O, editor. Biodiversity – The Dynamic Balance of the Planet. InTech; 2014. pp. 1–26. [DOI] [Google Scholar]
  35. Leal MC, Hilário A, Munro MH, Blunt JW, Calado R. Natural products discovery needs improved taxonomic and geographic information. Nat. Prod. Rep. 2016;33:747–750. doi: 10.1039/C5NP00130G. [DOI] [PubMed] [Google Scholar]
  36. Luesch H, Moore RE, Paul VJ, Mooberry SL, Corbett TH. Isolation of dolastatin 10 from the marine Cyanobacterium symploca species VP642 and total stereochemistry and biological evaluation of its analogue symplostatin 1. Journal of Natural Products. 2001a;64:907–910. doi: 10.1021/np010049y. [DOI] [PubMed] [Google Scholar]
  37. Luesch H, Yoshida WY, Moore RE, Paul VJ, Corbett TH. Total structure determination of apratoxin A, a potent novel cytotoxin from the marine Cyanobacterium lyngbya majuscula. Journal of the American Chemical Society. 2001b;123:5418–5423. doi: 10.1021/ja010453j. [DOI] [PubMed] [Google Scholar]
  38. Luesch H, Yoshida WY, Moore RE, Paul VJ. New apratoxins of marine cyanobacterial origin from guam and palau. Bioorganic & Medicinal Chemistry. 2002;10:1973–1978. doi: 10.1016/S0968-0896(02)00014-7. [DOI] [PubMed] [Google Scholar]
  39. Luzzatto-Knaan T, Melnik AV, Dorrestein PC. Mass spectrometry tools and workflows for revealing microbial chemistry. The Analyst. 2015;140:4949–4966. doi: 10.1039/C5AN00171D. [DOI] [PMC free article] [PubMed] [Google Scholar]
  40. McDonald D, Clemente JC, Kuczynski J, Rideout JR, Stombaugh J, Wendel D, Wilke A, Huse S, Hufnagle J, Meyer F, Knight R, Caporaso JG. The biological observation Matrix (BIOM) format or: how I learned to stop worrying and love the ome-ome. GigaScience. 2012;1:7. doi: 10.1186/2047-217X-1-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  41. Medema MH, Fischbach MA. Computational approaches to natural product discovery. Nature Chemical Biology. 2015;11:639–648. doi: 10.1038/nchembio.1884. [DOI] [PMC free article] [PubMed] [Google Scholar]
  42. Medema MH, Kottmann R, Yilmaz P, Cummings M, Biggins JB, Blin K, de Bruijn I, Chooi YH, Claesen J, Coates RC, Cruz-Morales P, Duddela S, Düsterhus S, Edwards DJ, Fewer DP, Garg N, Geiger C, Gomez-Escribano JP, Greule A, Hadjithomas M, Haines AS, Helfrich EJ, Hillwig ML, Ishida K, Jones AC, Jones CS, Jungmann K, Kegler C, Kim HU, Kötter P, Krug D, Masschelein J, Melnik AV, Mantovani SM, Monroe EA, Moore M, Moss N, Nützmann HW, Pan G, Pati A, Petras D, Reen FJ, Rosconi F, Rui Z, Tian Z, Tobias NJ, Tsunematsu Y, Wiemann P, Wyckoff E, Yan X, Yim G, Yu F, Xie Y, Aigle B, Apel AK, Balibar CJ, Balskus EP, Barona-Gómez F, Bechthold A, Bode HB, Borriss R, Brady SF, Brakhage AA, Caffrey P, Cheng YQ, Clardy J, Cox RJ, De Mot R, Donadio S, Donia MS, van der Donk WA, Dorrestein PC, Doyle S, Driessen AJ, Ehling-Schulz M, Entian KD, Fischbach MA, Gerwick L, Gerwick WH, Gross H, Gust B, Hertweck C, Höfte M, Jensen SE, Ju J, Katz L, Kaysser L, Klassen JL, Keller NP, Kormanec J, Kuipers OP, Kuzuyama T, Kyrpides NC, Kwon HJ, Lautru S, Lavigne R, Lee CY, Linquan B, Liu X, Liu W, Luzhetskyy A, Mahmud T, Mast Y, Méndez C, Metsä-Ketelä M, Micklefield J, Mitchell DA, Moore BS, Moreira LM, Müller R, Neilan BA, Nett M, Nielsen J, O'Gara F, Oikawa H, Osbourn A, Osburne MS, Ostash B, Payne SM, Pernodet JL, Petricek M, Piel J, Ploux O, Raaijmakers JM, Salas JA, Schmitt EK, Scott B, Seipke RF, Shen B, Sherman DH, Sivonen K, Smanski MJ, Sosio M, Stegmann E, Süssmuth RD, Tahlan K, Thomas CM, Tang Y, Truman AW, Viaud M, Walton JD, Walsh CT, Weber T, van Wezel GP, Wilkinson B, Willey JM, Wohlleben W, Wright GD, Ziemert N, Zhang C, Zotchev SB, Breitling R, Takano E, Glöckner FO. Minimum Information about a biosynthetic gene cluster. Nature Chemical Biology. 2015;11:625–631. doi: 10.1038/nchembio.1890. [DOI] [PMC free article] [PubMed] [Google Scholar]
  43. Mevers E, Matainaho T, Allara' M, Di Marzo, Gerwick WH. Mooreamide A: a cannabinomimetic lipid from the marine Cyanobacterium moorea bouillonii. Lipids. 2014;49:1127–1132. doi: 10.1007/s11745-014-3949-9. [DOI] [PubMed] [Google Scholar]
  44. Mushegian AA, Peterson CN, Baker CC, Pringle A. Bacterial diversity across individual lichens. Applied and Environmental Microbiology. 2011;77:4249–4252. doi: 10.1128/AEM.02850-10. [DOI] [PMC free article] [PubMed] [Google Scholar]
  45. Nguyen DD, Melnik AV, Koyama N, Lu X, Schorn M, Fang J, Aguinaldo K, Lincecum TL, Ghequire MG, Carrion VJ, Cheng TL, Duggan BM, Malone JG, Mauchline TH, Sanchez LM, Kilpatrick AM, Raaijmakers JM, Mot R, Moore BS, Medema MH, Dorrestein PC. Indexing the Pseudomonas specialized metabolome enabled the discovery of poaeamide B and the bananamides. Nature Microbiology. 2016;2:16197. doi: 10.1038/nmicrobiol.2016.197. [DOI] [PMC free article] [PubMed] [Google Scholar]
  46. Nguyen DD, Wu CH, Moree WJ, Lamsa A, Medema MH, Zhao X, Gavilan RG, Aparicio M, Atencio L, Jackson C, Ballesteros J, Sanchez J, Watrous JD, Phelan VV, van de Wiel C, Kersten RD, Mehnaz S, De Mot R, Shank EA, Charusanti P, Nagarajan H, Duggan BM, Moore BS, Bandeira N, Palsson BØ, Pogliano K, Gutiérrez M, Dorrestein PC. MS/MS networking guided analysis of molecule and gene cluster families. PNAS. 2013;110:E2611–E2620. doi: 10.1073/pnas.1303471110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  47. Nunnery JK, Mevers E, Gerwick WH. Biologically active secondary metabolites from marine cyanobacteria. Current Opinion in Biotechnology. 2010;21:787–793. doi: 10.1016/j.copbio.2010.09.019. [DOI] [PMC free article] [PubMed] [Google Scholar]
  48. Orjala J, Gerwick WH. Barbamide, a chlorinated metabolite with molluscicidal activity from the Caribbean Cyanobacterium lyngbya majuscula. Journal of Natural Products. 1996;59:427–430. doi: 10.1021/np960085a. [DOI] [PubMed] [Google Scholar]
  49. Owen JG, Charlop-Powers Z, Smith AG, Ternei MA, Calle PY, Reddy BV, Montiel D, Brady SF. Multiplexed metagenome mining using short DNA sequence tags facilitates targeted discovery of epoxyketone proteasome inhibitors. PNAS. 2015;112:4221–4226. doi: 10.1073/pnas.1501124112. [DOI] [PMC free article] [PubMed] [Google Scholar]
  50. Owen JG, Reddy BV, Ternei MA, Charlop-Powers Z, Calle PY, Kim JH, Brady SF. Mapping gene clusters within arrayed metagenomic libraries to expand the structural diversity of biomedically relevant natural products. PNAS. 2013;110:11797–11802. doi: 10.1073/pnas.1222159110. [DOI] [PMC free article] [PubMed] [Google Scholar]
  51. Passarini MR, Miqueletto PB, de Oliveira VM, Sette LD. Molecular diversity of fungal and bacterial communities in the marine sponge Dragmacidon reticulatum. Journal of Basic Microbiology. 2015;55:207–220. doi: 10.1002/jobm.201400466. [DOI] [PubMed] [Google Scholar]
  52. Pereira AR, Kale AJ, Fenley AT, Byrum T, Debonsi HM, Gilson MK, Valeriote FA, Moore BS, Gerwick WH. The carmaphycins: new proteasome inhibitors exhibiting an α,β-epoxyketone warhead from a marine Cyanobacterium. ChemBioChem. 2012;13:810–817. doi: 10.1002/cbic.201200007. [DOI] [PMC free article] [PubMed] [Google Scholar]
  53. Pereira AR, McCue CF, Gerwick WH. Cyanolide A, a glycosidic macrolide with potent molluscicidal activity from the Papua New Guinea Cyanobacterium lyngbya bouillonii. Journal of Natural Products. 2010;73:217–220. doi: 10.1021/np9008128. [DOI] [PMC free article] [PubMed] [Google Scholar]
  54. Protsyuk I, Ryazanov S, Alexandrov T. 95490e5a453dcdefe4627d6a8dfc32ec5b1ce92chttps://github.com/MolecularCartography/ili Web-based software for visualization of molecular maps in 2D and 3D. Github. 2017
  55. Purves K, Macintyre L, Brennan D, Hreggviðsson GÓ, Kuttner E, Ásgeirsdóttir ME, Young LC, Green DH, Edrada-Ebel R, Duncan KR. Using molecular networking for Microbial secondary metabolite bioprospecting. Metabolites. 2016;6:2. doi: 10.3390/metabo6010002. [DOI] [PMC free article] [PubMed] [Google Scholar]
  56. Rastogi RP, Sinha RP. Biotechnological and industrial significance of cyanobacterial secondary metabolites. Biotechnology Advances. 2009;27:521–539. doi: 10.1016/j.biotechadv.2009.04.009. [DOI] [PubMed] [Google Scholar]
  57. Sawada Y, Nakabayashi R, Yamada Y, Suzuki M, Sato M, Sakata A, Akiyama K, Sakurai T, Matsuda F, Aoki T, Hirai MY, Saito K. RIKEN tandem mass spectral database (ReSpect) for phytochemicals: a plant-specific MS/MS-based data resource and database. Phytochemistry. 2012;82:38–45. doi: 10.1016/j.phytochem.2012.07.007. [DOI] [PubMed] [Google Scholar]
  58. Schopf JW. The Fossil Record of Cyanobacteria. In: Whitton B. A, editor. Ecology of Cyanobacteria II: Their Diversity in Space and Time. London, United Kingdom: Springer; 2012. pp. 15–38. [DOI] [Google Scholar]
  59. Shannon P, Markiel A, Ozier O, Baliga NS, Wang JT, Ramage D, Amin N, Schwikowski B, Ideker T. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome Research. 2003;13:2498–2504. doi: 10.1101/gr.1239303. [DOI] [PMC free article] [PubMed] [Google Scholar]
  60. Sitachitta N, Williamson RT, Gerwick WH. Yanucamides A and B, two new depsipeptides from an assemblage of the marine cyanobacteria Lyngbya majuscula and Schizothrix species. Journal of Natural Products. 2000;63:197–200. doi: 10.1021/np990466z. [DOI] [PubMed] [Google Scholar]
  61. Tan LT, Goh BP, Tripathi A, Lim MG, Dickinson GH, Lee SS, Teo SL. Natural antifoulants from the marine Cyanobacterium lyngbya majuscula. Biofouling. 2010;26:685–695. doi: 10.1080/08927014.2010.508343. [DOI] [PubMed] [Google Scholar]
  62. Tan LT. Bioactive natural products from marine cyanobacteria for drug discovery. Phytochemistry. 2007;68:954–979. doi: 10.1016/j.phytochem.2007.01.012. [DOI] [PubMed] [Google Scholar]
  63. Tidgewell K, Engene N, Byrum T, Media J, Doi T, Valeriote FA, Gerwick WH. Evolved diversification of a modular natural product pathway: apratoxins F and G, two cytotoxic cyclic depsipeptides from a Palmyra collection of Lyngbya bouillonii. ChemBioChem. 2010;11:1458–1466. doi: 10.1002/cbic.201000070. [DOI] [PMC free article] [PubMed] [Google Scholar]
  64. Uzair B, Tabassum S, Rasheed M, Rehman SF. Exploring marine cyanobacteria for lead compounds of pharmaceutical importance. The Scientific World Journal. 2012;2012:179782–10. doi: 10.1100/2012/179782. [DOI] [PMC free article] [PubMed] [Google Scholar]
  65. Vázquez-Baeza Y, Pirrung M, Gonzalez A, Knight R. EMPeror: a tool for visualizing high-throughput microbial community data. GigaScience. 2013;2:16. doi: 10.1186/2047-217X-2-16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  66. Villa FA, Gerwick L. Marine natural product drug discovery: leads for treatment of inflammation, Cancer, infections, and neurological disorders. Immunopharmacology and Immunotoxicology. 2010;32:228–237. doi: 10.3109/08923970903296136. [DOI] [PubMed] [Google Scholar]
  67. Walsh CT. A chemocentric view of the natural product inventory. Nature Chemical Biology. 2015;11:620–624. doi: 10.1038/nchembio.1894. [DOI] [PubMed] [Google Scholar]
  68. Wan F, Erickson KL. Georgamide, a new cyclic depsipeptide with an alkynoic acid residue from an australian Cyanobacterium. Journal of Natural Products. 2001;64:143–146. doi: 10.1021/np0003802. [DOI] [PubMed] [Google Scholar]
  69. Wang M, Carver JJ, Phelan VV, Sanchez LM, Garg N, Peng Y, Nguyen DD, Watrous J, Kapono CA, Luzzatto-Knaan T, Porto C, Bouslimani A, Melnik AV, Meehan MJ, Liu WT, Crüsemann M, Boudreau PD, Esquenazi E, Sandoval-Calderón M, Kersten RD, Pace LA, Quinn RA, Duncan KR, Hsu CC, Floros DJ, Gavilan RG, Kleigrewe K, Northen T, Dutton RJ, Parrot D, Carlson EE, Aigle B, Michelsen CF, Jelsbak L, Sohlenkamp C, Pevzner P, Edlund A, McLean J, Piel J, Murphy BT, Gerwick L, Liaw CC, Yang YL, Humpf HU, Maansson M, Keyzers RA, Sims AC, Johnson AR, Sidebottom AM, Sedio BE, Klitgaard A, Larson CB, Boya P CA, Torres-Mendoza D, Gonzalez DJ, Silva DB, Marques LM, Demarque DP, Pociute E, O'Neill EC, Briand E, Helfrich EJ, Granatosky EA, Glukhov E, Ryffel F, Houson H, Mohimani H, Kharbush JJ, Zeng Y, Vorholt JA, Kurita KL, Charusanti P, McPhail KL, Nielsen KF, Vuong L, Elfeki M, Traxler MF, Engene N, Koyama N, Vining OB, Baric R, Silva RR, Mascuch SJ, Tomasi S, Jenkins S, Macherla V, Hoffman T, Agarwal V, Williams PG, Dai J, Neupane R, Gurr J, Rodríguez AM, Lamsa A, Zhang C, Dorrestein K, Duggan BM, Almaliti J, Allard PM, Phapale P, Nothias LF, Alexandrov T, Litaudon M, Wolfender JL, Kyle JE, Metz TO, Peryea T, Nguyen DT, VanLeer D, Shinn P, Jadhav A, Müller R, Waters KM, Shi W, Liu X, Zhang L, Knight R, Jensen PR, Palsson BØ, Pogliano K, Linington RG, Gutiérrez M, Lopes NP, Gerwick WH, Moore BS, Dorrestein PC, Bandeira N. Sharing and community curation of mass spectrometry data with global natural Products Social molecular networking. Nature Biotechnology. 2016;34:828–837. doi: 10.1038/nbt.3597. [DOI] [PMC free article] [PubMed] [Google Scholar]
  70. Watrous J, Roach P, Alexandrov T, Heath BS, Yang JY, Kersten RD, van der Voort M, Pogliano K, Gross H, Raaijmakers JM, Moore BS, Laskin J, Bandeira N, Dorrestein PC. Mass spectral molecular networking of living microbial colonies. PNAS. 2012;109:E1743–E1752. doi: 10.1073/pnas.1203689109. [DOI] [PMC free article] [PubMed] [Google Scholar]
  71. Whitton BA, Potts M. Introduction to the Cyanobacteria. In: Whitton B. A, editor. Ecology of Cyanobacteria II: Their Diversity in Space and Time. London, United Kingdom: Springer; 2012. pp. 1–13. [DOI] [Google Scholar]
  72. Williamson RT, Boulanger A, Vulpanovici A, Roberts MA, Gerwick WH. Structure and absolute stereochemistry of phormidolide, a new toxic metabolite from the marine Cyanobacterium phormidium sp. The Journal of Organic Chemistry. 2002;67:7927–7936. doi: 10.1021/jo020240s. [DOI] [PubMed] [Google Scholar]
  73. Wishart DS, Jewison T, Guo AC, Wilson M, Knox C, Liu Y, Djoumbou Y, Mandal R, Aziat F, Dong E, Bouatra S, Sinelnikov I, Arndt D, Xia J, Liu P, Yallou F, Bjorndahl T, Perez-Pineiro R, Eisner R, Allen F, Neveu V, Greiner R, Scalbert A. HMDB 3.0--the Human Metabolome database in 2013. Nucleic Acids Research. 2013;41:D801–D807. doi: 10.1093/nar/gks1065. [DOI] [PMC free article] [PubMed] [Google Scholar]
  74. Worley B, Powers R. Multivariate analysis in Metabolomics. Current Metabolomics. 2013;1:92–107. doi: 10.2174/2213235X11301010092. [DOI] [PMC free article] [PubMed] [Google Scholar]
  75. Yang JY, Sanchez LM, Rath CM, Liu X, Boudreau PD, Bruns N, Glukhov E, Wodtke A, de Felicio R, Fenner A, Wong WR, Linington RG, Zhang L, Debonsi HM, Gerwick WH, Dorrestein PC. Molecular networking as a dereplication strategy. Journal of Natural Products. 2013;76:1686–1699. doi: 10.1021/np400413s. [DOI] [PMC free article] [PubMed] [Google Scholar]
eLife. 2017 May 11;6:e24214. doi: 10.7554/eLife.24214.026

Decision letter

Editor: Emmanuel Gaquerel1

In the interests of transparency, eLife includes the editorial decision letter and accompanying author responses. A lightly edited version of the letter sent to the authors after peer review is shown, indicating the most substantive concerns; minor comments are not usually included.

Thank you for submitting your article "Digitizing mass spectrometry data to explore the chemical diversity and distribution of marine cyanobacteria and algae" for consideration by eLife. Your article has been reviewed by three peer reviewers, and the evaluation has been overseen by a Reviewing Editor and Ian Baldwin as the Senior Editor. The following individual involved in review of your submission has agreed to reveal his identity: Tim Bugni (Reviewer #3).

The reviewers have discussed the reviews with one another and the Reviewing Editor has drafted this decision to help you prepare a revised submission.

Summary:

This article by Luzzatto-Knaan et al. employs advances in MS/MS molecular networking developed in the Dorrestein lab to "capture the chemical space and dispersal patterns" of natural products from a set of samples from previous sample campaigns. The strength of the approach taken by the authors relies on the use of high-resolution MS/MS data to digitize the chemical inventory of the existing marine cyanobacteria and algae collection. This approach is combined with a systematic clustering, within the GNPS platform (https://gnps.ucsd.edu/), of the resulting molecular and fragmentation data according to compound families and in order to visualize the diversity, richness and geographical distribution of different classes of natural products.

Importantly, by placing non-targeted MS/MS structural data processing at the forefront, this study represents an important shift from previous natural screening procedures that are typically guided by low-to-medium-throughput molecule bioactivity screening procedures. This analysis also confirms that marine cyanobacterial/algal communities are significantly under-explored from a chemical perspective. As such, the vast amount of information rapidly parsed through the GNPS-based approach may guide the isolation of new groups of metabolites, like the newly described metabolite yuvalamide A or of derivatives of known groups of metabolites such as the barbamides analogs and yuvalamide B.

All three reviewers were generally positive about the work presented in this study. Especially, all agreed that the authors generated an impressive amount of data and presented elaborated classification and visualization approaches to systematically evaluate these data. As the GNPS database continues to grow, the types of analyses presented in this study will certainly be able to answer questions that were previously not tractable.

However, important concerns were raised regarding shortcomings in biological and geographical sampling design and how these hamper some of the conclusions drawn by the authors. Essential revisions are therefore needed in which conclusions most specifically with respect to geographical specificity should be toned down.

Essential revisions:

1) One major concern raised by the reviewers relates to the conclusions reached by the authors regarding geographical specificity. The observation of regiospecific clusters is interesting but since no targeted sampling covering the same phyla in the respective regions has been done, the clustering does not necessarily relate to the geographic location but may translate from sampling biases. Hence, a quantitative evaluation and discussion as performed in Figure 3 is problematic despite the effort for normalization. Also, plotting the data on a world map gives a nice picture but in the light of the small sample size (only 8 locations sampled) the suggested comprehensive global character of the study is not established. For all these reasons, generalizations in the text regarding the interpretation of regiospecific clusters are problematic and should be avoided during the revision: e.g. "To visualize the global distribution of select molecules" should rather read “to visualize the distribution […] in our 8 sampling sites ". Along with this, authors should remove the core conclusion that this study comprehensively visualizes molecules that are distributed based on geography. Instead, we recommend that authors highlight that, given the appropriate sampling strategy, the geographical importance of molecule distribution could be investigated via the tools presented.

2) Figures 2B and C do not clearly show regiospecific clustering. For example, the Papua New Guinea samples seem to be found throughout the figure. Since the figure is plotting dissimilarity relationships, it seems counterintuitive to use such a measure to understand regiospecific clustering. A similarity relationship might more clearly show regiospecific clustering. Also, while the collections of Panama are divided to three distinct locations the collections, in what I consider a larger area, Papua New Guinea is treated as one location. If one merges the diversities from Panama it gives the same percentage as PNG. Could the authors comment on this point, which echoes with the above recommendation to tone down conclusions about geographical specificity?

3) Another concern is related to the selection of organisms includes (quite arbitrary) benthic filamentous marine cyanobacteria and various classes of macro-algae (Rhodophyta, Chlorophyta and Phaeophyceae) predominantly collected from warm waters (Carribean, Indo-Pacific, Indian Ocean…). It is nice to see but no surprise that MS/MS features for marine cyanobacteria and algae are different from marine and terrestrial actinobacteria, lichens, freshwater cyanobacteria and corals. In relation with the previous points on geographic specificity, the authors should more explicitly acknowledge this biological bias in the text.

4) Along the same line, the authors state that "86.3% were features that were unique to these collections." In some way, the authors should provide a better method of capturing the current state of GNPS to provide a benchmark. While Figure 1C provides the number of molecular features, it would be useful to have a better understanding of the number of molecules present in GNPS at the time the comparison was made. Perhaps, this information is captured in Supplementary file 4. Looking at Figure 1C, it appears that most of GNPS might be comprised of data from cyanobacteria. How many of those features are represented in the current study? This information will be important for the reader to understand what the comparison entails.

[Editors' note: further revisions were requested prior to acceptance, as described below.]

Thank you for resubmitting your work entitled "Digitizing mass spectrometry data to explore the chemical diversity and distribution of marine cyanobacteria and algae" for further consideration at eLife. Your revised article has been favorably evaluated by Ian Baldwin (Senior Editor) and the Reviewing Editor.

The revised manuscript is an improvement in terms of clarity of interpretation of the region-specific metabolome mining analysis in light of technically-understandable shortcomings. Also, we agree with the authors that the lack of a comprehensive global character does not contradict the advances and potential impact of the work. However, we felt that the following points needed further considerations before this manuscript can be accepted for publication:

1) First, the Abstract still conveys the general idea that the authors conducted a comprehensive regio-specific analysis while only 8 sampling sites were considered. As discussed in the first round of review, this is a technically understandable shortcoming which does not alter the validity of the MS/MS and data analysis approaches, but the fact that the study is limited to 8 sampling sites should be stated in the Abstract.

2) The lower panel of Figure 2 which is referred to as panel C in the third paragraph of the subsection “Comparative metabolomics and chemical diversity of large scale datasets” is not labelled accordingly in the figure. This minor labelling discrepancy should be corrected.

3) Point 3 raised during the review concerned the interpretation of the comparison of features derived from Panama and Papua New Guinea (PNG) samplings to the overall chemical diversity across sampling sites. Most notably, if one merges the explained chemical diversities from Panama, it results in the same percentage as PNG. Considering the sampling diversity and existing metadata, the authors in their response to this point do not agree with the suggestion of merging the chemical diversity analyses inferred for each of the Panama current location categories. This argument for not merging the Panama location categories is reasonable; however, we feel that it remains inappropriate to draw the particular strong conclusion: "these numbers suggest that even though the sample sizes were similar, the detected chemical diversity varies greatly with PNG possessing the greatest chemical richness". This final sentence of the paragraph could be removed without altering the overall description of the value of the analytical approach used to explain sampling site-specific chemical diversity.

4) Finally, since the term "digitizing" or "digitization" is used in the title as well as throughout the text as a cornerstone step in the authors' workflow, it may be helpful for readers that one or two sentences are added to precisely define this term from a technical standpoint. Readers from different backgrounds will have different expectations as to what is meant by "digitizing".

eLife. 2017 May 11;6:e24214. doi: 10.7554/eLife.24214.027

Author response

Essential revisions:

1) One major concern raised by the reviewers relates to the conclusions reached by the authors regarding geographical specificity. The observation of regiospecific clusters is interesting but since no targeted sampling covering the same phyla in the respective regions has been done, the clustering does not necessarily relate to the geographic location but may translate from sampling biases. Hence, a quantitative evaluation and discussion as performed in Figure 3 is problematic despite the effort for normalization. Also, plotting the data on a world map gives a nice picture but in the light of the small sample size (only 8 locations sampled) the suggested comprehensive global character of the study is not established.

We thank the reviewers for raising this issue and would like to emphasize the limitations, considerations and benefits of this study. The main purpose on this work was to utilize a rare and unique collection of samples that has been collected for decades and with the abilities developed in our lab, to demonstrate the additional information that can be explored. Such unique collections exist in various laboratories that specializes in natural products studies that in many cases kept untouched for years or cleared out with academic turnovers. Seed banks and biodiversity collections also exist and may benefit from the potential this study is presenting as an example of longitudinal collections, where the technology is advancing far beyond the expectations when samples were actually collected or the purpose they were collected for. It is true that for this dataset we represent only 8 major locations, and we agree with the possibility of potential biases. However, these are the restrictions of the drug discovery effort that relies on authorizations and international permits for collecting biological material where the fate of the intellectual property outcome is clearly defined. As much as we would like to represent samples from the entire globe, we do not feel that the lack of it is contradicting the advances and potential this work is introducing. On the contrary, we highlight the publicly available tools developed in our labs (GNPS, QIIME and ili) to encourage their use and the sharing of information with labs that may have more comprehensive collections. The work presented and the analysis that is being made is illustrative of these tools; we feel that if we were not to present this analysis, the utility of these tools would not be apparent to the community.

For all these reasons, generalizations in the text regarding the interpretation of regiospecific clusters are problematic and should be avoided during the revision: e.g. "To visualize the global distribution of select molecules" should rather read “to visualize the distribution […] in our 8 sampling sites".

We appreciate and agree with the comment, and have changed the text according to reviewers’ suggestion as follows:

“To visualize the distribution of select molecules identified via molecular networking, in our 8 major sampling sites, MS/MS feature intensity values were projected onto a 2D geographical map based on GPS coordinates using the open-source tool ‘ili […]”

“While molecular networking revealed the locations with lowest and highest chemical diversity, visualizing these data on a world map enabled assessment of the distribution patterns of specific molecules within the eight sampled regions.”

Along with this, authors should remove the core conclusion that this study comprehensively visualizes molecules that are distributed based on geography. Instead, we recommend that authors highlight that, given the appropriate sampling strategy, the geographical importance of molecule distribution could be investigated via the tools presented.

We appreciate and agree with this important comment, and have added a note on this in the text as follows: “The geographical patterns of molecule distribution could be further investigated via the tools presented here, given the appropriate sampling strategy”.

2) Figures 2B and C do not clearly show regiospecific clustering. For example, the Papua New Guinea samples seem to be found throughout the figure. Since the figure is plotting dissimilarity relationships, it seems counterintuitive to use such a measure to understand regiospecific clustering. A similarity relationship might more clearly show regiospecific clustering.

We thank the reviewers for the comment and wish to clarify. The purpose of this analysis was to identify the differentiating metadata factor among these samples. Indeed, as mentioned in the text, based on the information in hand, the detected features of a single sample metabolome did not present a significant differentiation. Yet, it is important to mention that by looking at specific molecules, we do see regional specificities that we can account for in this dataset. To address reviewers’ concerns, we clarified the text as follows:

“Although our PCoA analysis did not indicate differentiation based on field annotations as algal versus cyanobacterial (Figure 2A), some geographic origin and regiospecific clustering was observed in this analysis (Figure 2B and C)”

Text was modified to: “Our PCoA analysis did not indicate differentiation based on field annotations as algal versus cyanobacterial (Figure 2A), and the non-significant clustering based on geographical origin highlights the vast chemical diversity of samples within the same region”

Also, while the collections of Panama are divided to three distinct locations the collections, in what I consider a larger area, Papua New Guinea is treated as one location. If one merges the diversities from Panama it gives the same percentage as PNG. Could the authors comment on this point, which echoes with the above recommendation to tone down conclusions about geographical specificity?

We appreciate and generally agree with this comment, but would like to emphasize the following considerations. The Panama region is divided into 4 major parts, two on the Pacific Ocean (PAC/PAG) and two on the Caribbean Sea (PAB/PAP), representing very different geographical environments (e.g. different oceans). The sampling density and repetitive collections from the same locations in different years was much higher for the Panama samples than for the PNG samples. Additionally, the metadata for the Panama region was much better documented and provided us with higher spatial resolution than for the PNG area. Taking these considerations together, we would like to keep the current location categories as presented.

3) Another concern is related to the selection of organisms includes (quite arbitrary) benthic filamentous marine cyanobacteria and various classes of macro-algae (Rhodophyta, Chlorophyta and Phaeophyceae) predominantly collected from warm waters (Carribean, Indo-Pacific, Indian Ocean…). It is nice to see but no surprise that MS/MS features for marine cyanobacteria and algae are different from marine and terrestrial actinobacteria, lichens, freshwater cyanobacteria and corals. In relation with the previous points on geographic specificity, the authors should more explicitly acknowledge this biological bias in the text.

We thank the reviewer for highlighting this point. However, the difference in features as expected or “non-surprising” as they are, were never shown before, and if so, were not possible for comparison at this scale before the GNPS platform. The purpose of this study was to discover additional information from a well-studied collection of marine cyanobacteria and algae that have already yielded many new compounds for drug discovery efforts. The various classes of cyanobacteria and algae were field identifications from samples collected over the past 30 years and did not reveal any distinct classification. Also, it should be taken under account that these are environmental samples that harbor complex communities. Although, there are biases that may come from every step along the collection and analysis process, and this is something that needs to be kept in mind. Following this comment, we have emphasized this further in the text:

“However, not only is PNG a biodiversity hotspot, molecular networking quantitatively revealed that this region is rich in the presence of unique natural products compared to other locations sampled in this study”.

“As we can see in this dataset, presented here for illustrative purposes of the tools available in GNPS, most molecules are broadly distributed in disparate physical locations, whereas others are highly specific to particular locations.”

4) Along the same line, the authors state that "86.3% were features that were unique to these collections." In some way, the authors should provide a better method of capturing the current state of GNPS to provide a benchmark. While Figure 1C provides the number of molecular features, it would be useful to have a better understanding of the number of molecules present in GNPS at the time the comparison was made. Perhaps, this information is captured in Supplementary file 4. Looking at Figure 1C, it appears that most of GNPS might be comprised of data from cyanobacteria. How many of those features are represented in the current study? This information will be important for the reader to understand what the comparison entails.

This is an important point, since by using GNPS, the data is kept “alive” and we are happy to address this comment:

At the time the comparison was made, GNPS held thousands of library standards from: FDA (>2300 spectra) NIH ((>3000) spectra from clinical collections, natural products library and active small molecules), Faulkner natural products legacy library (>120 spectra), Prestwick Phytochemical library (140 spectra), Massbank (>10000 spectra), HMBD (>2200 spectra), licensed NIST 2014 (for our in-house use) and the GNPS user contributions (>1500 spectra). In addition, our dataset is publicly available and undergoing continuous identification, meaning that every once in a while, all available datasets are reannotated against the updated library; hence additional annotations appear over time. We encourage scientists that are interested in our dataset (or any other) to subscribe to GNPS and get email updates once additional standards are annotated.

The number of annotated spectra and molecular families in this dataset at the time this work was processed is presented in the last paragraph of the subsection “Comparative metabolomics and chemical diversity of large scale datasets”.

We refer readers to the full dataset (Supplementary file 2) that is open for everyone to “rerun” against the updating library.

[Editors' note: further revisions were requested prior to acceptance, as described below.]

1) First, the Abstract still conveys the general idea that the authors conducted a comprehensive regio-specific analysis while only 8 sampling sites were considered. As discussed in the first round of review, this is a technically understandable shortcoming which does not alter the validity of the MS/MS and data analysis approaches, but the fact that the study is limited to 8 sampling sites should be stated in the Abstract.

We appreciate the editors comment and followed it, to state the fact that 8 major locations are presented. However, in order stay within the restricted word limit of the Abstract we removed the description of the compared datasets.

“Remarkably, 86% of the metabolomics signals detected were not found in other available datasets of similar nature, supporting the hypothesis that marine cyanobacteria and algae possess distinctive metabolomes. The data were plotted onto a world map representing 8 major sampling sites, and revealed potential geographic locations with high chemical diversity.”

2) The lower panel of Figure 2 which is referred to as panel C in the third paragraph of the subsection “Comparative metabolomics and chemical diversity of large scale datasets” is not labelled accordingly in the figure. This minor labelling discrepancy should be corrected.

Thank you for this comment. We have corrected accordingly, and referenced to the panels of Figure 2B only.

3) Point 3 raised during the review concerned the interpretation of the comparison of features derived from Panama and Papua New Guinea (PNG) samplings to the overall chemical diversity across sampling sites. Most notably, if one merges the explained chemical diversities from Panama, it results in the same percentage as PNG. Considering the sampling diversity and existing metadata, the authors in their response to this point do not agree with the suggestion of merging the chemical diversity analyses inferred for each of the Panama current location categories. This argument for not merging the Panama location categories is reasonable; however, we feel that it remains inappropriate to draw the particular strong conclusion: "these numbers suggest that even though the sample sizes were similar, the detected chemical diversity varies greatly with PNG possessing the greatest chemical richness". This final sentence of the paragraph could be removed without altering the overall description of the value of the analytical approach used to explain sampling site-specific chemical diversity.

We truly thank the editors for highlighting the issue and for the suggested solution. We have followed this comment and removed the sentence accordingly.

4) Finally, since the term "digitizing" or "digitization" is used in the title as well as throughout the text as a cornerstone step in the authors' workflow, it may be helpful for readers that one or two sentences are added to precisely define this term from a technical standpoint. Readers from different backgrounds will have different expectations as to what is meant by "digitizing".

We thank the editors for this comment and agree that this might be interoperate by readers in various ways. We have added a short explanation in parenthesis:

“In this study, we used a mass spectrometry based approach to digitize (convert to data format that can be stored, shared and analyzed by computational tools) the chemical inventory of an established marine cyanobacteria and algae collection in order to better evaluate its diversity and probe for novel natural products.”

One additional error was spotted and corrected. The text referred to Figure 1D and was corrected to 1C.

Associated Data

    This section collects any data citations, data availability statements, or supplementary materials included in this article.

    Supplementary Materials

    Supplementary file 1. Samples list and metadata.

    Sample list and metadata are freely available upon registration at http://qiita.microbio.me Study ID:10125. Also refers to Figures 2, 3, 4 and 5.

    DOI: http://dx.doi.org/10.7554/eLife.24214.015

    elife-24214-supp1.xlsx (445KB, xlsx)
    DOI: 10.7554/eLife.24214.015
    Supplementary file 2. Supplemental table 1: GNPS molecular networking MS/MS based identification of molecules and molecular families – Refers to Figures 3 and 4.

    DOI: http://dx.doi.org/10.7554/eLife.24214.016

    elife-24214-supp2.docx (708.1KB, docx)
    DOI: 10.7554/eLife.24214.016
    Supplementary file 3. 2D NMR spectroscopic data for amino acids residues of yuvalamide A.

    13C and 1H chemical shifts were determined by HSQC and HMBC spectra. Hiv = 2 hydroxyisovaleric acid (600 MHz for 1H, 125 for 13C), the solvent (DMSO-d6) and the temperature (298K).

    DOI: http://dx.doi.org/10.7554/eLife.24214.017

    elife-24214-supp3.docx (16.5KB, docx)
    DOI: 10.7554/eLife.24214.017

    Articles from eLife are provided here courtesy of eLife Sciences Publications, Ltd

    RESOURCES